Gothenburg, Sweden

Maria Carlsson

This inventor holds 1 USPTO granted patent. Top assignee: A. Carlsson Research Ab. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Carlsson. Retrieved from https://idiyas.com/inventor/maria-carlsson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria Carlsson: Innovator in Neurodevelopmental Disorder Treatments

Introduction

Maria Carlsson is a prominent inventor based in Göteborg, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodevelopmental disorders. Her innovative work has led to the development of a unique compound that holds promise for improving patient outcomes.

Latest Patents

Maria Carlsson holds 1 patent for her invention titled "Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders." This patent discloses the use of a compound with a specific formula, wherein various substituents can be employed to create a pharmaceutical composition aimed at treating neurodevelopmental disorders. The method involves administering a therapeutically effective amount of the compound to patients, showcasing her commitment to advancing medical science.

Career Highlights

Maria is associated with A. Carlsson Research AB, where she continues to explore innovative solutions in the pharmaceutical industry. Her work is characterized by a strong focus on research and development, particularly in the area of neurodevelopmental disorders.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Maria Carlsson's contributions to the field of neurodevelopmental disorder treatments exemplify her dedication to innovation and research. Her patent reflects a significant advancement in pharmaceutical science, promising better treatment options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…